Pharmaceutical Preparations · WA · CIK 1285819
Omeros discovers and develops protein and small-molecule therapeutics for complement-mediated diseases, cancers, and addictive disorders
Comparable business profile · signals at a glance
In the 90 days to Jan 13, 2026: 1 sold $751K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 13, 2026 | Borges David J.VP, Finance & CAO | Sell | 30,000 | $12.31 | $369K |
| Jan 12, 2026 | Borges David J.VP, Finance & CAO | Sell | 30,000 | $12.72 | $382K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.